BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17090392)

  • 1. Intranasal vaccination with a double mutant of staphylococcal enterotoxin C provides protection against Staphylococcus aureus infection.
    Hu DL; Omoe K; Narita K; Cui JC; Shinagawa K; Nakane A
    Microbes Infect; 2006; 8(14-15):2841-8. PubMed ID: 17090392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutant of staphylococcal enterotoxin C devoid of bacterial superantigenic activity elicits a Th2 immune response for protection against Staphylococcus aureus infection.
    Hu DL; Cui JC; Omoe K; Sashinami H; Yokomizo Y; Shinagawa K; Nakane A
    Infect Immun; 2005 Jan; 73(1):174-80. PubMed ID: 15618152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection.
    Hu DL; Omoe K; Sasaki S; Sashinami H; Sakuraba H; Yokomizo Y; Shinagawa K; Nakane A
    J Infect Dis; 2003 Sep; 188(5):743-52. PubMed ID: 12934191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-10 (IL-10) Produced by Mutant Toxic Shock Syndrome Toxin 1 Vaccine-Induced Memory T Cells Downregulates IL-17 Production and Abrogates the Protective Effect against Staphylococcus aureus Infection.
    Narita K; Hu DL; Asano K; Nakane A
    Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31358568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
    Hu DL; Narita K; Hyodo M; Hayakawa Y; Nakane A; Karaolis DK
    Vaccine; 2009 Jul; 27(35):4867-73. PubMed ID: 19406185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with glutathione S-transferase and mutant toxic shock syndrome toxin 1 fusion protein protects against Staphylococcus aureus infection.
    Cui JC; Hu DL; Lin YC; Qian AD; Nakane A
    FEMS Immunol Med Microbiol; 2005 Jul; 45(1):45-51. PubMed ID: 15985222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with plasmid DNA encoding a mutant toxic shock syndrome toxin-1 ameliorates toxin-induced lethal shock in mice.
    Feng MH; Cui JC; Nakane A; Hu DL
    Tohoku J Exp Med; 2013 Sep; 231(1):1-8. PubMed ID: 23985881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with non-toxic mutant toxic shock syndrome toxin-1 induces IL-17-dependent protection against Staphylococcus aureus infection.
    Narita K; Hu DL; Asano K; Nakane A
    Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25857736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal vaccination with adjuvant-free S. aureus antigens effectively protects mice against experimental sepsis.
    Stegmiller NP; Barcelos EC; Leal JM; Covre LP; Donatele DM; de Matos Guedes HL; Cunegundes MC; Rodrigues RR; Gomes DC
    Vaccine; 2016 Jun; 34(30):3493-9. PubMed ID: 27091687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal immunization of mutant toxic shock syndrome toxin 1 elicits systemic and mucosal immune response against Staphylococcus aureus infection.
    Narita K; Hu DL; Tsuji T; Nakane A
    FEMS Immunol Med Microbiol; 2008 Apr; 52(3):389-96. PubMed ID: 18312579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of glutathione S-transferase-fused mutant staphylococcal enterotoxin C against Staphylococcus aureus-induced bovine mastitis.
    Cui JC; Zhang BJ; Lin YC; Wang QK; Qian AD; Nakane A; Hu DL; Tong GZ
    Vet Immunol Immunopathol; 2010 May; 135(1-2):64-70. PubMed ID: 19959244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The double adjuvants LTB and CpG significantly enhanced the immuno-protective effects of recombinant GIT derived from Staphylococcus aureus and Streptococcus in mice.
    Ma J; Yu L; Song B; Yu Y; Zhang S; Wei Y; Wu Z; Yao D; Yu W; Zhu Z; Cui Y
    J Med Microbiol; 2018 Mar; 67(3):432-440. PubMed ID: 29458538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity.
    Nilsson IM; Verdrengh M; Ulrich RG; Bavari S; Tarkowski A
    J Infect Dis; 1999 Oct; 180(4):1370-3. PubMed ID: 10479175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of a Staphylococcus aureus-cholera toxin A
    Misra N; Wines TF; Knopp CL; Hermann R; Bond L; Mitchell B; McGuire MA; Tinker JK
    Vaccine; 2018 Jun; 36(24):3513-3521. PubMed ID: 29739718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DS-Nh as an experimental model of atopic dermatitis induced by Staphylococcus aureus producing staphylococcal enterotoxin C.
    Yoshioka T; Hikita I; Matsutani T; Yoshida R; Asakawa M; Toyosaki-Maeda T; Hirasawa T; Suzuki R; Arimura A; Horikawa T
    Immunology; 2003 Apr; 108(4):562-9. PubMed ID: 12667219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of recombinant staphylococcal enterotoxin type C mutant vaccine against experimental bovine infection by a strain of Staphylococcus aureus isolated from subclinical mastitis in dairy cattle.
    Chang BS; Moon JS; Kang HM; Kim YI; Lee HK; Kim JD; Lee BS; Koo HC; Park YH
    Vaccine; 2008 Apr; 26(17):2081-91. PubMed ID: 18387721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-17A plays an important role in protection induced by vaccination with fibronectin-binding domain of fibronectin-binding protein A against Staphylococcus aureus infection.
    Narita K; Asano K; Nakane A
    Med Microbiol Immunol; 2017 Jun; 206(3):225-234. PubMed ID: 28378247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T and B cells are not required for clearing Staphylococcus aureus in systemic infection despite a strong TLR2-MyD88-dependent T cell activation.
    Schmaler M; Jann NJ; Ferracin F; Landmann R
    J Immunol; 2011 Jan; 186(1):443-52. PubMed ID: 21131426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Titer Persistent Neutralizing Antibodies Induced by TSST-1 Variant Vaccine Against Toxic Shock Cytokine Storm.
    Roetzer A; Stich N; Model N; Schwameis M; Firbas C; Jilma B; Eibl MM
    Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33023185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A D-Alanine auxotrophic live vaccine is effective against lethal infection caused by Staphylococcus aureus.
    Moscoso M; GarcĂ­a P; Cabral MP; Rumbo C; Bou G
    Virulence; 2018 Jan; 9(1):604-620. PubMed ID: 29297750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.